Dr Stephen Luen and the Peter Mac Early Drug Development Fellows will share selected abstracts that were presented at the American Society of Clinical Oncology 2026 conference that highlight new drug developments in precision oncology and Phase 1 clinical trials. This includes novel targeted therapies and antibody drug conjugates that are entering the clinical space, and have the potential to transform standard cancer treatment paradigms.
The Forum is a comprehensive educational initiative offering multi-disciplinary insights into Precision Oncology. Monthly sessions feature expert presentations, interactive discussions, and real-world case studies, aimed at scientists, clinicians, industry professionals, and students.
Cases are discussed on an individual, de-identified basis.
Dr Huiling Xu
Senior Research Fellow, Peter MacCallum Cancer Centre
Dr Joep Vissers
Curation Scientist Team Leader, the University of Melbourne
Dr Stephen Luen
Medical Oncologist, Peter MacCallum Cancer Centre
Dr Jason Qin
Early Drug Development Fellow, Peter MacCallum Cancer Centre
Dr Ishan Mehta
Early Drug Development Fellow, Peter MacCallum Cancer Centre
Dr Harriet O’Rourke
Early Drug Development Fellow, Peter MacCallum Cancer Centre
Content warning: The VCCC Alliance Precision Oncology Forum is aimed primarily at a clinical audience and features open discussion about real cases and patients. While these cases are de-identified, the imagery, content and discussion can be graphic.
